y milestones in the last 6 months. In July 2013, the Principals agreed to invest S0.8m at a valuation of 417m post money. Other investors included Illumina and Arch Ventures. Bo re al Boreal is a molecular information company focused on cancer detection and monitoring in circulating tumour DNA through a simple blood dra